Stock BAVARIAN NORDIC A/S
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Bavarian Nordic A/S CBOE EUROPE EQUITIES

Equities

DK0015998017

Real-time Estimate Cboe Europe
Other stock markets
 10:07:05 2024-07-05 EDT
177.2 DKK 0.00% Intraday chart for Bavarian Nordic A/S
07-01 Bavarian Nordic Turns DKK1 Billion Facility into Sustainability-linked Loan MT
06-28 Nordic Stocks Rose Friday; Millicom International Cellular Climbed Highest DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan
GL
Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa
GL
Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA
GL
Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
GL
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
GL
Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa
GL
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
GL
Bavarian Nordic A/S : Transactions in Connection with Share Buy Back Program and Termination of Share Buy Back Program
PU
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
GL
EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic
GL
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
GL
Bavarian Nordic A/S : Interim Results (Q1) as of 31 March 2024
PU
Bavarian Nordic Announces Interim Results for the First Three Months of 2024
GL
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
GL
Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve
GL
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
GL
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS
AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
GL
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S
GL
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAVA Stock
  4. Stock
  5. News Bavarian Nordic A/S
  6. Press Releases